GB201720624D0 - Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations - Google Patents
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbationsInfo
- Publication number
- GB201720624D0 GB201720624D0 GBGB1720624.4A GB201720624A GB201720624D0 GB 201720624 D0 GB201720624 D0 GB 201720624D0 GB 201720624 A GB201720624 A GB 201720624A GB 201720624 D0 GB201720624 D0 GB 201720624D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cyanobenzoyl
- methylbenzamide
- pyrazol
- cyclopropyl
- prevention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1720624.4A GB201720624D0 (en) | 2017-12-11 | 2017-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations |
DK18819366.8T DK3585383T3 (en) | 2017-12-11 | 2018-12-11 | USE OF 3- [5-AMINO-4- (3-CYANOBENZOYL) -PYRAZOL-1-YL] -N-CYCLOPROPYL-4-METHYLBENZAMIDE IN THE PREVENTION OF ACUTE EXTENSIONS OF CHRONIC OBSTRUCTIVE |
JP2020531614A JP7372680B2 (en) | 2017-12-11 | 2018-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease. |
PL18819366T PL3585383T3 (en) | 2017-12-11 | 2018-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease |
AU2018381874A AU2018381874A1 (en) | 2017-12-11 | 2018-12-11 | Use of 3-(5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl)-N-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease |
CA3085544A CA3085544A1 (en) | 2017-12-11 | 2018-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease |
EP21156673.2A EP3845228A1 (en) | 2017-12-11 | 2018-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease |
EP18819366.8A EP3585383B1 (en) | 2017-12-11 | 2018-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease |
PT188193668T PT3585383T (en) | 2017-12-11 | 2018-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease |
ES18819366T ES2882978T3 (en) | 2017-12-11 | 2018-12-11 | Use of 3- [5-amino-4- (3-cyanobenzoyl) -pyrazol-1-yl] -N-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease |
HUE18819366A HUE054266T2 (en) | 2017-12-11 | 2018-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease |
PCT/GB2018/053591 WO2019116022A1 (en) | 2017-12-11 | 2018-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease |
US15/733,213 US11234967B2 (en) | 2017-12-11 | 2018-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease |
KR1020207019714A KR20200097310A (en) | 2017-12-11 | 2018-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbation of chronic obstructive pulmonary disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1720624.4A GB201720624D0 (en) | 2017-12-11 | 2017-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201720624D0 true GB201720624D0 (en) | 2018-01-24 |
Family
ID=61007027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1720624.4A Ceased GB201720624D0 (en) | 2017-12-11 | 2017-12-11 | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201720624D0 (en) |
-
2017
- 2017-12-11 GB GBGB1720624.4A patent/GB201720624D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1253580A1 (en) | Use of cannabinoids in the treatment of epilepsy | |
GB2568809B (en) | Use of cannabinoids in the treatment of epilepsy | |
GB2568471B (en) | Use of cannabinoids in the treatment of epilepsy | |
PT3334422T (en) | Use of cannabinoids in the treatment of epilepsy | |
IL274769A (en) | Use of cannabinoids in the treatment of epilepsy | |
GB201713872D0 (en) | Autonomous delivery of items | |
ZA202006636B (en) | Use of sublingual dexmedetomidine for the treatment of agitation | |
GB201411496D0 (en) | Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy | |
HUE048545T2 (en) | Duplex stainless steel and use thereof | |
IL264813B (en) | 2-oxo-imidazopyridines and their use | |
ZA201605222B (en) | Pyrazolone compounds and uses thereof | |
HK1249851A1 (en) | Treatment and prevention of the common cold using povidone-iodine | |
ZA201806511B (en) | Glycoalkaloid combinations and various uses thereof | |
PT3585383T (en) | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease | |
GB201720624D0 (en) | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations | |
PL3585382T3 (en) | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease | |
ZA201902263B (en) | Helical impeller | |
AP00792S1 (en) | Water purification and dispensing divice | |
GB201700340D0 (en) | fluid manipulation cartridge and controller mechanism | |
PL3327201T3 (en) | Container and use of the same | |
GB201720622D0 (en) | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary | |
PL3106172T3 (en) | Antimicrobial agents and their use | |
EP3308038C0 (en) | Hydraulic valve body and hydraulic valve mechanism comprising the body | |
GB201707017D0 (en) | Narrow boat construction | |
GB201616087D0 (en) | Algae comprising therapeutic and/or nutritional agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |